primary hyperoxaluria type 1

FDA Approves Novo Nordisk's Rivfloza, Setting Stage for Market Duel with Alnylam

FDA Approves Novo Nordisk’s Rivfloza, Setting Stage for Market Duel with Alnylam

Anika Sharma

Novo Nordisk, known for its popular obesity therapy Wegovy, has achieved a significant milestone with the FDA approval of Rivfloza, ...